10X Genomics
Adam Taich is an accomplished finance and strategy executive with extensive experience in the biotechnology and life sciences sectors. Currently serving as the Chief Financial Officer at 10x Genomics, Adam previously held the position of Chief Strategy Officer at Standard BioTools and served as both Chief Executive Officer and Chief Business Officer at SomaLogic. Adam's background also includes leadership roles at Thermo Fisher Scientific, where responsibilities encompassed Vice President and General Manager positions across Molecular Biology and Protein and Cell Analysis, as well as Vice President of Strategy and Business Development. Early in the career, Adam began in mergers and acquisitions as an Associate at Donaldson, Lufkin & Jenrette. Adam Taich earned a BA in Political Science and Russian from Miami University, following an education at Mary Institute and St. Louis Country Day School.
This person is not in any offices
10X Genomics
18 followers
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend, and have been cited in over 3,000 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,200 issued patents and patent applications.